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Abstract
The frequent human pathogen Staphylococcus aureus requires a sufficient
source of iron to proliferate and, thus, to sustain an infection of a mammalian host.
However, the free iron concentration in the host is insufficient for bacterial growth
without use of specialized uptake mechanisms. To overcome this, S. aureus utilizes
multiple systems to scavenge host iron. One such strategy that S. aureus employs is the
use of siderophores: secreted, small-molecular-weight, high-affinity iron chelators. S.
aureus synthesizes and secretes two anionic a-hydroxycarboxylate siderophores,
staphyloferrin A (SA) and staphyloferrin B (SB). Fe-SA and Fe-SB complexes are
transported into the cell through the highly specific ABC-type transporters HtsABC and
SirABC, respectively. The crystal structures of HtsA, the SA receptor, have been solved
for both SA bound and unbound forms. Structural data indicate that HtsA has a unique
positively charged binding pocket and many charged residues form contacts with the
anionic siderophore including R86, R104, R126, K203, H209, and Y239. Their
contribution to productive binding and transport is currently unknown. To investigate
the role of each residue found to interact with SA, site-directed mutagenesis was used to
substitute each interacting residue with either alanine or an amino acid with more
conserved properties. Fluorescence titrations of SA, produced and purified in vitro, with
wild-type (WT) or mutant rHtsA were used to determine the effect that each
substitution had on the binding affinity of HtsA for SA. Growth curves and diskdiffusion assays were completed on strains expressing mutated or WT HtsA to
determine the biological significance of each mutation under SA-dependant growth
conditions. These studies have confirmed significant roles in SA binding and transport
iii

for HtsA residues R104, R126, and H209, strengthening the conclusions drawn from the
HtsA crystal structure and providing new insight into the mechanism of SA-dependant
iron uptake in S. aureus.

Key Words: Staphylococcus aureus, ABC-transporters, HtsABC, iron transport,
siderophores, staphyloferrin A
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Chapter 1 - Introduction
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1.1. Staphylococci
1.1.1. Staphylococcus genus
Staphylococcus is derived from the Greek work staphylé which means “bunch of
grapes”, which describes their characteristic grape-like appearance when observed under
a microscope (30). They belong to the family Staphylococcaceae which includes
Jeotgalicoccus, Micrococcus, Nosocomicoccus, and Salinoccus. Staphylococci are
spherical (approximately 1 pm in diameter), Gram-positive, facultative-anaerobes, that
are non-motile and non-spore-forming. Depending on growth conditions, they can be
found alone, in pairs, strings, or in clusters because their cell division occurs in more
than one plane. They tend to form capsules in vivo, however, they produce little to no
capsule when grown under standard laboratory conditions (105). They have a thick cell
wall that consists of peptidoglycan with glycine cross-links, and wall teichoic acids and
lipoteichoic acids (30).

1.1.2. Staphylococcus aureus
Staphylococcus aureus is a commensal and a pathogen. It produces a yellow
carotenoid pigment, staphyloxanthin, distinguishing it from other staphylococci (123). S.
aureus is one of few coagulase-positive staphylococci (CoPS) that harbour the gene
encoding coagulase in their genome. The enzyme coagulase interacts with host factors in
serum to clot blood, which may aid in immune evasion (126). S. aureus is the best
studied species of staphylococci however, some notable coagulase-negative
staphylococci (CoNS) include S. saprophyticus, S. haemolyticus, and S. epidermidis (72).

One of S. aureus’ ecological niches is the anterior nares of humans. Approximately 2030% of the population are persistent S. aureus carriers, and an additional 30% are
intermittent carriers (152). More than eighty strains of S. aureus and 6 CoNS strains
have had their complete genome sequenced. S. aureus genomes range from roughly 2.8
to 2.9Mbp and have an average G + C mol % content of 33% (69).

1.1.3. S. aureus pathogenesis
S. aureus is a significant human pathogen and is frequently responsible for blood,
skin, soft tissue, and lower respiratory tract infections in North America and Europe (38).
It is also the leading cause of nosocomial infections in the United States (140) and
community-acquired (CA) infections are becoming increasingly prevalent (77).
Furthermore, the CA strains tend to be more invasive than the traditional hospital
acquired strains (79). S. aureus can infect multiple host tissue environments and cause
mild infections including impetigo, pimples, boils, and food poisoning to more severe
infections including toxic shock syndrome, osteomyelitis, pneumonia, necrotizing
fasciitis, bacteraemia, sepsis, and staphylococcal scalded skin syndrome (150).
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1.1.4. S. aureus virulence factors
The ability of S. aureus to produce productive infections in many different host
tissue environments is largely due to its enormous repertoire of virulence factors. S.
aureus encodes both structural and secreted virulence factors and many of them are
encoded on mobile genetic elements (MGEs). Through transfer of genetic information,
the MGEs increase the heterogeneity of S. aureus virulence factors and resistance
determinants (95). Antibiotic resistance will be discussed in greater detail below. Many
types of MGEs are found in S. aureus including plasmids, transposons, insertion
sequences, bacteriophages, pathogenicity islands, and staphylococcal cassette
chromosomes. Most staphylococcal MGEs are regulated by core genome global
regulators allowing for careful regulation of virulence factor expression (37).
Adhesion of S. aureus to host molecules is achieved through microbial surface
components recognizing adhesive matrix molecules (MSCRAMMs) (111). The
MSCRAMM family of proteins includes a fibronectin-binding protein (FnBPA), a
collagen-binding protein (Cna), clumping factor A (ClfA), and a fibrinogen-binding
protein (142, 111), among others. Other surface proteins include protein A (Spa), which
binds the Fc domain of immunoglobulin G (IgG), aiding immune evasion (142). It can
also mediate attachment to host von Willebrand factor, a blood glycoprotein involved in
hemostasis (63). S. aureus also has an elastin binding protein (EbpS) and can bind other
host plasma and extra-cellular matrix (ECM) components, however, the mechanisms
remain unclear.
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Different strains of S. aureus have the ability to secrete a large variety of
virulence factors, including exoenzymes such as proteases, lipases, and nucleases, and
exotoxins, including a , p, y, and 5 toxins, Panton-Valentine Leukocidin (PVL),
superantigens (SAgs), and superantigen-like proteins, and exfoliative toxins A and B.
Collectively, these factors function to provide nutrients, modulate host immune
mechanisms and damage tissues (36).
Regulation of staphylococcal virulence factors is essential for maintaining
productive infections. Two global regulator families are responsible for proper virulence
factor regulation. They are two component regulatory systems (TCRS) and the
staphylococcal accessory regulator (SarA) protein family (16). Of 16 known S. aureus
TCRSs the most notable system involved in pathogenesis is the accessory gene regulator
(agr) quorum sensing system (22). The agr system is cell density dependant and at
elevated cellular densities, such as those during post-exponential growth phase, the agr
system increases secreted toxin production and decreases surface protein expression
(148, 107). Additional TCRSs involved ins', aureus pathogenesis include SaeRS, (55,
56), ArlRS (48, 49), and SrrAB (154).
The SarA protein family consists of DNA-binding proteins that directly or
indirectly regulate at least 120 staphylococcal genes. Furthermore, it has been
demonstrated that SarA is required for the complete activation of agr expression (21).
SarA levels are highest during the late exponential phase of growth leading to the
highest expression levels of the fibronectin and fibrinogen binding protein adhesins and
toxins that promote dispersion (22). Additionally, it represses Spa and protease
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expression (22). SarA elicits its effects directly by binding gene promoters, indirectly via
downstream effects of regulons, or by stabilizing mRNA transcripts (22, 121).

1.1.5. S. aureus antibiotic resistance
S. aureus antibiotic resistance is a growing problem in nosocomial and CA
infections. S. aureus develop resistance through a number of mechanisms. One of the
first mechanisms identified was the production of a secreted penicillinase (BlaZ), which
hydrolytically cleaves (3-lactams (19). More recently, methicillin resistant
Staphylococcus aureus (MRSA), which is propagated on MGEs (SCCmec), have
become a growing concern (61). There are currently 8 SCCmec types, abbreviated I-VIII,
which have been subdivided into 5 classes. Each class contains mecA, which encodes a
low-affinity penicillin binding protein (PBP2a) that prevents binding of methicillin or
other 13-lactam antibiotics (20).
In addition to mecA, other antibiotic resistance determinants are frequently
associated with the SSCmec MGEs. These include resistance to erythromycin (ermB,
ermC), spectinomycin (aad9 or spc), tetracycline (tet), aminoglycosides (aacA-aphD),
bleomycin (ble), and tobramycin (ant4 ’) (36). More recently, staphylococci have
acquired vancomycin resistance from enterococci resulting in vancomycin-resistant S.
aureus (VRSA) (151). Vancomycin resistance is mediated by VanA and VanH which
synthesize a D-Ala-D-Lac precursor that has reduced affinity for glycopeptide
antibiotics (89). In addition, VanX mediates the elimination of the D-Ala-D-Ala peptides
that are susceptible to glycopeptide antibiotics, thus eliminating the drug targets (88).
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Consequently, there is a drastic need for the identification of new therapeutic targets,
such as the interruption of access to the essential nutrient iron.

1.2. Iron
Iron is an essential nutrient for almost all living organisms. The only known
exceptions are some lactobacilli (1) and spirochaetes (116). Iron exists predominantly in
two oxidative states, ferrous Fe2+(FeII) or ferric Fe3+(FeIII). The ability to transition
between those oxidative states is essential for the catalytic roles that iron has in most
organisms (114). Indeed, iron can be found in essential enzymes involved in the electron
transport chain, carbon utilization, DNA replication, and oxygen metabolism (4).

1.3. Iron solubility
Although iron constitutes a significant proportion of the earth, the vast majority
of it is unavailable for biological activity. This is largely due to the rapid oxidation of
ferrous iron by molecular oxygen (104). The resulting iron-hydroxide precipitates are
stable and extremely insoluble culminating into a final free iron concentration of
approximately 10'9M at a neutral pH (118).

1.4. Iron in the human host
Further evidence of iron’s biological importance is demonstrated by a human
host’s non-specific defence mechanisms that function to limit iron availability. Most
iron is found intracellulary complexed to haemoglobin (76%) or ferritin (23%) (109).
Additionally, extracellular iron-binding proteins, especially transferrin and lactoferrin,
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further depress the free iron available leading to essentially no free iron in the host (118).
The abundance of iron binding proteins involved in proper iron homeostasis and
maintenance of low extracellular levels within a human host highlight iron’s importance.
Heightened iron levels can bolster infections, as patients with thalassemia or other forms
of iron overload are more susceptible to infections (149), or it can lead to the production
of free radicals under aerobic conditions. However, insufficient iron has severe
consequences on essential cellular processes including oxygen transport, electron
transport, and RNA and DNA synthesis. Furthermore, during an infection iron is
actively sequestered by the reticuloendothelial system (90). Therefore, iron limitation in
the human host is a significant obstacle that microorganisms must overcome in order to
sustain infections.

1.5. Regulation of iron uptake
Proper organization and regulation of iron transport is an essential process. The
most important iron-regulatory protein is the ferric uptake regulator (Fur), an irondependant repressor protein found in both Gram-negative and Gram-positive bacteria,
including S. aureus (146), and more than 60 homologues have been found (15). Other
iron-responsive repressor proteins have been identified, such as RirA-type regulatory
proteins; however, Fur is by far the most important (139, 146). Under physiologically
adequate levels of cellular iron Fur binds ferrous iron. Dimeric Fur-Fe(II) complexes
then bind specific DNA regulatory sequences at Fur boxes, a 19-bp inverted repeat,
located within the operator region of target genes and repress transcription (62, 158). Fur
regulates more than 90 E. coli genes in this manner (139). Additionally, it has been
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demonstrated that Fur can also indirectly activate genes through repression of small
RNA silencing molecules (98) and directly upregulate other genes (35).

1.6. Bacterial iron acquisition strategies
Many organisms have developed means of scavenging human host iron. Due to
iron’s strict limitation, multiple strategies are frequently employed by successful
pathogens. These systems work in concert to access and internalize host iron sources.
For instance, some bacteria secrete toxins that lyse host cells in order to gain access to
intracellular iron stores. Additionally, other systems can recognize host extracellular iron
containing sources.

1.6.1. Ferric reductases
One mechanism that bacteria use to acquire host iron is to reduce highly
insoluble ferric iron (lO '18M) to much more soluble ferrous iron (0.1 M) at a pH of 7.0
(4). Listeria monocytogenes has two of the best-characterized examples of ferric
reductases. One is membrane-bound with a broad range of activity and the other is
secreted and can reduce and remove iron from transferrin (28). Ferric reductase activity
has now been shown in a number of bacterial (46), fungal (43), and plant species (44).
Additionally, some organisms have a specific transport system for ferrous iron. For
example, the feo system which was first identified in E. coli, is also present in S.
enterica (11) and H. pylori, other colonizers of the human intestinal tract and stomach,
respectively. It is anaerobically induced where conditions are more permissive for
ferrous iron (76). A homologous system has also been identified in S. aureus (65).
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1.6.2. Host iron-binding protein receptors
Some bacteria encode surface receptors that specifically recognize human host
iron-binding glycoproteins as an iron source. Neisseria gonorrhoeae has two transferrin
(Tf)-binding proteins, TbpA and TbpB (130), and two lactoferrin (Lf)-binding proteins
that form Tf and Lf receptors on its cell surface (131). Other human pathogens, such as
Haemophilus influenzae, have similar receptors (132). Both receptors bind Tf or Lf and
remove iron for internalization without transporting the glycoproteins across the outer
membrane (OM). These OM receptors have a (3-barrel structure similar to porins
however, an N-terminal globular domain prevents free diffusion of substrates into the
periplasm. Instead, transport is dependent on TonB-ExbB-ExbD, an inner membrane
embedded protein complex that interacts with a TonB box within the N-terminal
globular domain of the OM receptors in order to facilitate transport (13). Iron is then
bound by periplasmic substrate binding proteins which deliver the cargo to inner
membrane ABC transporters which shuttle the cargo through the inner membrane (IM)
in an ATP-consuming fashion (3).
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1.6.3. Heme iron acquisition
Heme is a protoporphyrin ring with a centrally located iron atom. It is a
hydrophobic prosthetic group found in many proteins and it is the most abundant
potential iron source in the human host (109). It is found primarily intracellulary,
however, following lysis of erythrocytes it is released into the extracellular milieu (115).
In order to prevent damage from reactive heme molecules, it is quickly sequestered by
hemopexin (73), lipoprotein (101), haemosiderin (71), or haptoglobin (53). Host
macrophages will then internalize and clear the haptoglobin-hemoglobin or hemopexinheme complexes, protecting the host from damage and limiting bacterial heme access
(83). Under physiological conditions this highly efficient process reduces heme
concentrations beneath detection limits in human serum (115). However, during an
infection many bacteria, including S. aureus, secrete haemolysins that lyse erythrocytes
and elevate the extracellular heme concentration (8). Several Gram-positive and Gram
negative bacterial systems have been identified that use heme as an iron source. Indeed,
there are three types of heme transport systems that can obtain heme from host sources
including hemopexin, haemoglobin, heme-albumin, and haemoglobin-haptoglobin (145).

1.6.3.1. Direct heme uptake systems
Direct heme uptake systems have been identified in Gram-negative and Gram
positive bacteria. In Gram-negative bacteria, heme is bound at the outer membrane and
transported into the periplasm in a TonB-dependant fashion. It is then complexed to a
heme transport protein (HTP) and shuttled into an ABC-transporter for internalization
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into the cytosol (145). The Pseudomonas aeruginosa phuR-phuSTUVW is an example of
a direct heme uptake system that contains an outer membrane receptor (PhuR), an HTP
(PhuS), an ABC-transporter (PhuUVW), and a cytosolic protein (PhuS) (108). Similar
systems are utilized by several other Gram-negative pathogens including Yersinia pestis,
Campylobacter jejuni, and E. coli (102, 144, 147). There are fewer well-described heme
transport systems in Gram-positive bacteria. S. aureus encodes an iron-regulated surface
determinate system (Isd) that is composed of four cell wall-anchored proteins
(IsdABCH), an ABC transporter (IsdDEF), and two heme oxygenases (IsdGH) (120).
The surface proteins, IsdB and IsdH, bind haemoglobin or haemoglobin-haptoglobin
(41) from which IsdA extracts heme and passes it to IsdC. Heme is then shuttled to
IsdDEF which transports it across the cell membrane into the cytoplasm (106). The
heme oxygenases then extract the iron for incorporation into proteins or storage (99,
120). The Isd locus is also found in other Gram-positive pathogens (145) however,
Corynebacterium spp. and Streptococcus spp. use a direct heme uptake system that is
distinct from Isd (2, 157). In C. diptheriae, htaCA hmuTUV-htaB encodes two heme
receptors (HtaA & HtaB), a heme binding protein (HmuT) and an ABC-transporter
(HmuUV) that internalizes the heme (2).
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I.6.3.2. Hemophores
Both Gram-positive and Gram-negative hemophores have been identified. A
hemophore is a secreted heme-binding protein that scavenges heme and is then
recognized by a surface receptor that mediates heme uptake. Two Gram-negative
hemophore systems have been characterized (145). The HasA hemophore system
consists of a hemophore (HasA), an exporter (HasDEF), a receptor (HasR), two
regulatory proteins (HasI and HasS) (52, 124) and is TonB- or the TonB homolog,
HasB-dependant (110). This system has been identified in Serratia marcescens, P.
aeruginosa, P. fluorescens, and Y. pestis (74, 91, 125). The HxuA hemophore system
has only been identified in Haemoplilus influenzae type b and it consists of a hemophore
(HxuA) that binds heme-hemopexin complexes, an exporter (HxuB), and a receptor
(possibly HxuC) (26). Bacillus anthracis encodes the only known Gram-positive
hemophores, IsdXl and IsdX2. The hemophores are unique components of an Isd heme
uptake system that is similar to but distinct from the S. aureus Isd (51). IsdXl can
remove heme from haemoglobin before passing it to IsdX2 or IsdC, which then
transports heme into the cell through the Isd system (47).
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1.6.4. Siderophores
Another common iron acquisition strategy that is utilized by an large number of
bacteria is siderophores. A siderophore is a secreted, small (500-1500 Da), high-affinity
Fe(III) chelator. There is an incredible diversity of siderophore structures and origins
with more then 500 currently identified and structural information for more than half of
them (65). Siderophores have been identified in plants (44), fungi (45), and
microorganisms (50).

I.6.4.I. Siderophore biosynthesis
There are two classes of siderophore biosynthesis: nonribosomal peptide
synthesis (NRPS) and nonribosomal peptide synthesis-independent (NIS) (18). NRPS
synthesis occurs in a step-by-step process, usually through the addition of amino acids or
their derivatives to a proteinaceous backbone by a large modular multienzyme (29).
These complexes are not limited to the production of siderophores but are also
responsible for the synthesis of most microbial peptide secondary metabolites including
some antibiotics such as penicillin (129) and vancomycin (141). Some notable NRPS
siderophores include enterobactin and yersiniabactin (119). NIS pathways usually rely
on multiple synthetases that combine dicarboxcylic acids with diamines, alcohols, and
amino alcohols (18). The best-known example of an NIS siderophore is aerobactin,
assembled by two enzymatic synthetases (34). Interestingly, the siderophore
petrobactin’s synthesis is partially completed by both NRPS and NIS systems (85, 113).
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I.6.4.2. Siderophore structure
Although there is incredible diversity in the structure of siderophores, they can be
classified according to their iron-coordinating moieties. Three types of siderophore iron
coordinating moieties have been documented (Fig. 1). The first type of functional group
is a hydroxymate group, which uses both carbonyl and aminohydroxyl groups to
coordinate iron as seen in desferrioxamine B (Fig. 2) (143). The second functional group
incorporates a catecholate structure, which coordinates iron with two adjacent hydroxyl
groups as seen in enterobactin (Fig. 2) (75). Lastly, there are polycarboxylate groups,
which coordinate iron with either a-hydroxycarboxylates or carboxylic acid moieties as
seen in staphyloferrin A (SA) (Fig. 2). This thesis will primarily focus on SA, an ahydroxycarboxylate siderophore (100). Additionally, there are mixed-type siderophores
that use combinations of the above functional groups to coordinate iron, such as
aerobactin (Fig. 2) (65).
Although siderophores use a hexadentate structure to coordinate Fe(III) with an
octahedral geometry, the stoichiometric relationship between siderophores and Fe(III)
varies (65). Depending on the number of coordinating residues that a siderophore
contains, they can form mono-, di-, or multi-nucleate iron complexes with one or more
siderophore molecules involved (66). Additionally, some siderophores rely on solvent
molecules to complete the hexa-coordinated complex (29).

—

*

Figure 1. Types of siderophore iron coordinating moieties. Illustrated are the three
major siderophore functional groups involved in Fe(III) coordination; catecholate,
hydroxamate, and carboxylate. Each group is bi-dentate. Red oxygen atoms can donate
electrons to coordinate Fe(III).
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Figure 2. Types of siderophores. Illustrated are examples of the four types of
siderophores classified according to their Fe(III)-coordinating moieties. Catecholateenterobactin; hydroxamate-desferrioxamine B; polycarboxylate-staphyloferrin A; and
mixed-type-aerobactin.
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1.7. S. aureus siderophores
S. aureus has a profound ability to adapt to host environments and has multiple
methods of accessing host iron. Not surprisingly, several staphylococcal genetic loci
have been identified that are involved in siderophore biosynthesis or transport. To date,
two S. aureus siderophores have been identified; staphyloferrin A (SA) (80, 100) and
staphyloferrin B (SB) (40, 60).

1.7.1. Staphyloferrin A
SA is a 480 Da a-hydroxycarboxylate siderophore that was first isolated from
iron-starved culture supernatant of S. hyicus (100). It is comprised of two citrate
molecules linked, via amide bonds, to D-omithine and has the chemical identity of
7v2,A5-di-(l-oxo-3-hydroxy-3,4-dicarboxybutyl)-D-ornithine. It is stable between 4°C
and 80°C in neutral aqueous solution (80). The SA biosynthesis genes were identified
through bioinformatics searches using the aerobactin NIS synthetases IucA and IucC as
queries. A four-gene locus, sfaABCD, was identified in all sequenced staphylococci
including S. epidermidis, S. saprophyticus, S. aureus, and S. haemolyticus (7). SA was
also identified in culture supernatants of S. aureus and S. epidermidis and its production
is stimulated by supplementation with D-omithine (100). The sfa locus consists of a
three-gene operon, sfaABC, and a divergently transcribed gene, sfaD. Upstream from
two divergent promoters, intergenically between sfaA and sfaD, are two Fur box
consensus sequences that provide Fur transcriptional control in S. aureus (7). However,
constitutive production of SA in some CoNS suggests a lack of Fur regulation (96).

The genes of the sfaABCD locus encode two NIS synthetases, SfaB and SfaD, a
putative pyridoxal-5’-phosphate (PLP)-dependant D-ornithine racemase, SfaC, and a
putative SA efflux protein, SfaA (27). Cotton et al. demonstrated that purified SfaB and
SfaD can generate SA in vitro from citrate and D-omithine (27). The complete
biochemical synthesis reaction is illustrated in Figure 3. SfaD is responsible for the
committing step of synthesis, condensing citric acid and D-omithine, and SfaB
completes the molecule through condensation of citric acid and the 5-citryl-D-ornithine
intermediate.
Chromosomal deletion of sfaABCD in S. aureus abrogates SA production however,
if SB is still produced it does not result in an observable growth defect in mammalian
serum (SB will be discussed below). Although this suggests that SA may not be the
major contributor of transferrin iron, a more drastic growth deficit is observed in an SA
and SB deficient mutant than a SB deficient mutant alone (7). Furthermore, SA has been
demonstrated to remove iron from human and porcine transferrin (103, 6). Chromosomal
deletion of sfaABCD in S. aureus can be complemented via plasmid-bome sfa genes
from S. aureus or S. epidermidis, demonstrating functional conservation of the
staphylococcal sfa locus despite protein sequence identities of 50-80% (7).

Figure 3. Staphyloferrin A biosynthesis pathway.
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1.7.2. Staphyloferrin B
SB is a 448 Da a-hydroxycarboxylate siderophore that was initially purified and
structurally characterized from iron-starved culture supernatant of S. hyicus (60). It is
comprised of L-2,-3-diamino-propionic acid (DAPA), citrate, ethyldiamine (EDA), and
a-ketoglutarate (a-KG) (40). The SB biosynthesis genes were also identified through
bioinformatic searches of the aerobactin NIS synthetases IucA and IucC as queries. A
nine-gene operon, sbnABCDEFGHI, was identified in S. aureus (32). SB was also
identified in culture supernatants of S', aureus and some CoNS (100, 40). Interestingly,
Gram-negative Ralstonia solanacearum and Cupriavidus metallidurans also produce SB
(9, 5). The sbn operon contains a Fur box consensus sequence located in the operator
region that provides Fur-dependent transcriptional control of the operon (32).
The genes o f the sbnABCDEFGHI operon encode three NIS synthetases, SbnC,
SbnE, and SbnF, a putative ornithine cyclodeaminase, SbnB, a putative L-O-acetylserine
sulfhydrylase, SbnA, a putative SB efflux protein, SbnD (32), a PLP-dependant
decarboxylase, SbnH, and two proteins with currently undefined functions, SbnG and
Sbnl (23). Cheung et al. demonstrated that purified SbnC, SbnE, SbnF, and SbnH can
generate SB in vitro from DAP A, a-KG and citrate (23). SbnE is responsible for the first
step of synthesis, condensing DAPA and citric acid to form a citryl-L-2,3-diaminopropionic acid intermediate. It is then decarboxylated by SbnH, forming citryldiaminoethane, before a second DAPA molecule is condensed onto it by SbnF. Finally,
SbnC completes SB through condensation of a-KG and L-2,3-diaminopropionyl-citryldiaminoethane.
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Chromosomal deletion of sbnABCDEFGHI in S. aureus abrogates SB production
and impairs growth in serum. Although growth is not completely abolished, presumably
due to the presence of SA, it suggests a significant role in iron acquisition from
transferrin (7).

1.8. Siderophore-mediated iron acquisition
Gram-positive and Gram-negative bacteria require active transport systems to
transport ferric-siderophores across their cell membrane because they are too large for
passive diffusion. Although smaller siderophores (less than 600Da) may passively
diffuse through porins in the Gram-negative outer membrane, siderophores generally
require an energy-dependant carrier protein to cross this barrier (14). The cell wall of
Gram-positive bacteria does not represent a barrier to movement of ferric-siderophores.

1.8.1. ATP-binding cassette transporters
Gram-positive and Gram-negative bacteria use ATP-binding cassette (ABC)family transporters to import ferric siderophores across their cell membrane into the
cytoplasm. They belong to one of the largest paralogous sequence superfamilies and
consist of a receptor, a transmembrane permease, and a highly conserved ATPase (128).
More than 600 ABC-transporters have been identified (33) and they are found
ubiquitously among all genera of the three kingdoms of life (70).
There are three major classes of ABC-systems; importers, exporters, and a third
class that is involved in mRNA translation and DNA repair. Each class is further
subdivided into subclasses and families and this thesis will focus on class III binding-

protein-dependant (BPD) importers (33). These ABC-transporters have separate
polypeptide TM, ABC, and substrate binding domains (117). The generic structure of
ABC-transporters can be seen in Figure 4. Substrates for these ABC-transporters include
mono- and oligosaccharides, ions, amino acids, short peptides, ferric-siderophores (the
focus of this thesis), metals, polyamine cations, opines, and vitamins (39). The beststudied examples o f these ABC-transporters are the high-affinity histidine and maltose
transport systems o f Salmonella enterica serovar Typhimurium and E. coli (54).
Many iron ABC-transporters are important virulence factors (64). Furthermore,
many bacteria encode transporters for exogenous siderophores (i.e. xenosiderphores;
siderophores produced by other organisms). For example, the S. aureus Fhu transporter
is involved in the uptake of hydroxamate siderophores (produced mainly by fungi)
despite lacking the necessary biosynthesis machinery to produce this type of molecule

Figure 4. Schematic of Gram-negative and Gram-positive siderophore-mediated ironuptake pathways. A) Gram-negative bacteria have outer-membrane receptors that bind
and transfer siderophores to periplasmic binding proteins in a TonB-ExbB-ExbDdependent process. The ligand-bound periplasmic binding protein then associates with
its cognate ABC-transporter in the inner membrane, which transports the siderophore
into the cytoplasm. B) Gram-positive bacteria have lipoprotein receptors, homologous to
Gram-negative periplasmic binding proteins, which bind siderophores and associate with
their cognate ABC-transporter in the cellular membrane, which transports the
siderophore into the cytoplasm. PBP, periplasmic binding protein; TMD, transmembrane
domain.
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1.8.2. S. aureus siderophore transporters
Given that S. aureus is such a successful human pathogen it is not surprising that
many iron-regulated ABC-transporters are encoded within its genome. To date, one
heme transporter (IsdEF) (32) and four siderophore transporters have been identified and
characterized (57, 58, 6). The latter transporters are HtsABC (Fe(III)-SA), SirABC
(Fe(III)-SB), FhuCBG-Dl-D2 (Fe(III)-hydroxamate siderophores) and SstABCD
(Fe(III)-catecholamines/catechols) (6).

1.8.3. The staphyloferrin B receptor: SirA
The sir locus encodes a lipoprotein receptor, SirA, and two heterodimeric
permeases, SirBC (32). FhuC provides the ATPase activity that is necessary for Fe-SB
transport (138). A chromosomal deletion of sirA or sirB abolishes SB transport in S.
aureus (32). Also, heterologous expression of sirABC in S. epidermidis allows SBdependant growth (5). The crystal structures of apo- and holo-SirA have been solved,
positively identifying SB in the substrate binding-pocket (57).
The Fe-SB-rSirA crystal structure was among the first Gram-positive
siderophore receptors to be structurally characterized (57). It has a class-III binding fold
between separate N- and C-terminal domains that are linked by a single a-helix (57).
Both N- and C-terminal domains contain a central parallel (3-sheet that is surrounded by
short a-helices (57). Although most class III binding protein crystal structures reveal
that ligand binding results in either subtle or hinged-motion conformational changes,
both the Fe-SB-SirA and Fe-SA-HtsA crystal structures reveal localized conformational

changes in the C-terminal loops of the binding site. However, different regions of each
receptor’s C-terminal domain undergo the largest conformational changes (57, 58).
Furthermore, fluorescence quenching experiments using Fe-SB, Fe-SA, and Fedesferrioxamine demonstrated that SirA is highly specific for Fe-SB. Therefore, the
unique structural features of HtsA and SirA are likely responsible for their ability to
distinguish between the two a-hydroxycarboxylate siderophores (57, 58).
SirA forms a total of nine contact points with Fe-SB. Three arginine residues
form five hydrogen-bonds (H-bonds) with three Fe-SB oxygen atoms and two nitrogen
atoms. R125 forms two salt bridges with the Fe(III) coordinating carbonyl of the a-KG
component and citrate group (57). R201 forms a H-bond with the carbonyl oxygen that
links the Fe-SB DAPA and citrate groups and R206 forms salt bridges to the a-KG and
citrate components. Finally, T144 forms an H-bond with the Cl 1-C12 amide linkage,
Y208 forms an H-bond with the citrate carboxylate group, and N304 forms an additional
polar contact with the citrate carboxylate group. Comparison of apo- and holo-SirA
revealed that the majority of intradomain conformational change was maximal in the Cterminal loops. The movements help to occlude Fe-SB in the binding pocket, reducing
solvent exposure to 23.6%. Among the SirA residues, N263 moves the greatest distance
of 11.3 A and others are brought into closer proximity with Fe-SB, likely facilitating
some of the H-bonds identified (57).

1.8.4. The staphyloferrin A receptor: HtsA
The hts locus was first described and named as a “heme-transport system”,
following the observation that transposon disruption of hts resulted in preferential uptake
of transferrin Fe(III) over heme Fe(II) (137). However, a chromosomal deletion of
htsABC abolishes SA transport in S. aureus (7). Furthermore, the crystal structures of
apo- and two forms of holo-HtsA have been solved, positively identifying SA in the
substrate binding-pocket (Figure 5A, B, and C)(7, 58). It was the first Gram-positive (7)
and first a-hydroxycarboxylate siderophore receptor to be structurally characterized
(58). Table 1 lists the dissociation constants (KJ) of Fe-SA-rHtsA and several related
proteins. Their significance will be discussed in more detail in later sections.

Figure 5. HtsA crystal structure. A) Surface electrostatics of HtsA. The binding groove
is a large positively charged region. Blue, white, and red indicate positive, neutral, and
negative potential, respectively. B) HtsA undergoes localized conformational changes
following binding of Fe-staphyloferrin. Illustrated is an overlay of the open and closed
forms and the apo-conformations of the HtsA crystal structures. Open conformation, red;
closed conformation, blue; apo-conformation, green. Staphyloferrin A is shown in the
binding pocket of the open-conformation. C) Coordination and binding of staphyloferrin
A in the HtsA binding pocket. On the left is the open conformation of staphyloferrin A
in the HtsA binding pocket. On the right is the closed conformation of staphyloferrin A
in the HtsA binding pocket. HtsA residues forming contacts with SA are cyan sticks,
with carbon, nitrogen, oxygen, and iron shown as green, blue, red, and orange,
respectively. Hydrogen-bonds are represented by dashed lines (58). In the open
conformation R299 is modeled in two positions within H-bonding distance from Fe-SA.

33

34

.

Table 1 Dissociation constants for receptor-ferric-siderophore complexes
Dissociation
Reference
Ligand
Protein“ Organism
Constant ( K d )
Low nM
(58)
staphyloferrin A
S. aureus
HtsA
19
nM
(155)
bacillibactin
FeuA
B. cereus
12 nM
(155)
enterobactin
FeuA
B. cereus
(155)
1.3 nM
3,4-DHB
B. cereus
FatB
(155)
127 nM
petrobactin
B. cereus
FatB
(155)
175 nM
petrobactin
B. cereus
FpuA
(155)
34 nM
schizokinen
B. cereus
YfiY
(155)
18 nM
desferroximine
B. cereus
YxeB
(156)
113
nM
petrobactin
B. subtilis
YclQ
Ferric-hy droxamates 300-7900 nM (122)
FhuD
E. coli
(68)
0.37 nM
pyoverdin
P. aeruginosa
FpvA6
(68)
0.65 nM
ferrichrome
P. aeruginosa
FhuA*
0.54 nM
pyochelin
P. aeruginosa
_i68)________
FplA*
*Proteins are class III ligand-binding proteins unless otherwise stated.
b Gram-negative Outer membrane receptor proteins.
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HtsA has a class-III binding fold between separate N- and C-terminal domains
that are linked by a single a-helix (58). Similar to SirA, both N- and C-terminal domains
contain a central parallel (3-sheet that is surrounded by short a-helices (57, 58). Its
structure is similar to other class III binding proteins including BtuF {E. coli B 12 uptake)
(10, 78), TroA (E. coli Zn2+ uptake) (86, 87), FhuD (E. coli ferrichrome uptake) (24, 82),
and ShuT (Shingella dysenteriae heme uptake) (67) however, it has a novel form of
ligand entrapment (58). The two holo-HtsA forms represent distinct open and closed
conformations. The conformational change results from isolated movements of three
loops within the C-terminal domain and is unique among class III binding proteins (Fig.
5B) (58).
HtsA forms six contact points with Fe-SA in the open conformation (Fig 5C).
Five arginine residues form hydrogen bonds (H-bonds) with oxygen atoms of Fe-SA.
R104 and R126 form H-bonds with Fe-SA. R299 is modeled in two positions within Hbond proximity of a Fe-SA ornithine hydroxyl group and R304 and R306 form H-bonds
with a terminal Fe-SA carboxylate group. H209 forms another H-bond with the Fe-SA
ornithine hydroxyl group and four water molecules are modeled within H-bond
proximity of the Fe-SA ornithine carboxylate group, carbonyl group, and two
carboxylate groups of one of the citrate molecules (58). Loop movements leading to the
closed conformation result in the additional contacts with Fe-SA, shift it deeper into the
binding pocket, and reduce solvent exposure from 33.0 to 14.5%. Y239 moves the
greatest distance, 12.1 A, before forming a H-bond with a citrate carbonyl group. The
closed conformation also allows K203 and R86 to H-bond with Fe-SA carboxylate
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groups (Fig. 5C). Although several of the contact points remain the same, several of the
H-bond lengths are reduced in the closed structure (58).

1.9 Research objectives
The goal of this research is to further characterize S. aureus SA transport and to
provide a model system for a-hydroxycarboxylate siderophore transport. The first
research objective was to synthesize and purify SA for use in receptor binding and
bacterial growth assays. The second research objective was to use site-directed
mutagenesis to mutate HtsA residues predicted by the holo-HtsA crystal structure to
mediate binding and/or transport of Fe-SA. Finally, the last research objective was to
determine the effects of each residue substitution on Fe-SA binding affinity and their
biological significance under iron-restricted or SA-dependent growth conditions.

Chapter 2 - Materials and Methods
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2.1. Bacterial strains and growth conditions
The bacterial strains used in this study are described in Table 2. Unless otherwise
indicated, bacteria were cultured at 37°C. Antibiotics were used at the following
concentrations: for E. coli, ampicillin (Ap) 100 pg mL'1, kanamycin (Km) 30 pg mL'1,
choramphenicol (Cm) 30 pg mL'1, and for S. aureus, Km 50 pg mL'1, Cm 5 pg mL'1,
neomycin (Nm) 50 pg m L'1, tetracycline (Tc) 4 pg mL'1, erythromycin (Em) 3 pg mL'1.
For molecular-genetic manipulations, E. coli was grown in Luria-Bertani broth (LB),
and S. aureus was grown in tryptic soy broth (TSB). For experiments completed under
iron-limiting growth conditions, Tris-minimal succinate (TMS), prepared as described
(135), was used. To further control the bioavailable iron, growth media was
supplemented with 50 pM FeCf, 10 pM ethylenediamine-di-o-hydroxyphenylacetic
acid (EDDHA) (LGC Promochem), or treated with 10% w/v Chelex® 100 resin (BioRad) overnight at 4°C and supplemented with 20% v/v heat-inactivated horse-serum. All
solutions and growth media were made with water purified by a Milli-Q purification
system (Millipore Corp). Solid media was obtained by addition of 1.5% w/v Bacto-agar
(Difco). Cultures were stored at -80°C in 15% v/v glycerol.
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Table 2. Bacterial strains used in this study
Description“
Strain
S. aureus

Source or reference

Newman
RN4220
H1497
E. coli

Wild-type clinical isolate
rtTmk+; accepts foreign DNA
Newman AhtABC::Tc As7/vl::Km; TcR KmR

(42)
(81)
(7)

DH5a

cp8odLacZAMl 5 recAl endAl gyrA96 thi-1
hsdR17{rk‘mk+) supE44 relAl deoR A(lacZYAargF) U169
F T fhuA2 [Ion] ompT lacZ::T7 genel gal
su lA ll A(mcrC-mrr)\\4::lS 10R(mcr73::mimTnlO)2 R(zgb-2\0::Tn 10) 1 (Tets)
endAl \dcni\
F_, ompT, hsdSs (rs-, ms-), dcm, gal, 7(DE3),
pLysS, CmR.

Promega

ER2566

BL21

New England Biolabs

Promega

Abbreviations: TcR, KmR, and CmR, resistance to tetracycline, kanamycin, and chloramphenicol,
respectively.
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2.2. Recombinant DNA methodology
2.2.1. Plasmid isolation from E. coli
The plasmids used in this study are described in Table 3. Manipulation of
recombinant DNA was completed as described (127). Plasmid DNA was isolated from E.
coli using QIAprep mini-spin kits (QIAgen) or E.Z.N.A™ Plasmid Miniprep Kit II
(Omega Bio-Tek), according to the manufacturer’s directions. All centrifugation was
completed at 14 000 x g, unless otherwise indicated. Typically, approximately 2 mL of
stationary phase E. coli was harvested by centrifugation (10 000 x g) and resuspended in
250 pL of PI buffer. Cell lysis was achieved via addition of 250 pL of buffer P2
(Qiagen), gentle inversion, and incubation for 5 minutes. The solution was neutralized
via addition of 350 pL of N3 buffer, mixed by inversion, and centrifuged for 10 minutes
to pellet insoluble material. The supernatant was applied to the QIAprep spin column
and centrifuged for 1 minute. The spin column was washed with 750 pL of PE buffer
and centrifuged twice for 1 minute to remove excess ethanol. Plasmid DNA was eluted
from the resin and into a microcentrifuge tube via centrifugation (12000 x g) after
addition of 50 pL of 42°C ddH20 to the resin.
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Table 3. Plasmids used in this study
Source or reference
Description0
Plasmid
pET28a(+) Vector for overexpression of His-tagged proteins Novagen
using the T7 bacteriophage promoter
(7, 58)
pET28a(+) derivative encoding the soluble
pEV99
portion of HtsA; KmR
(84)
E. coli/S. aureus shuttle vector; ApR CmR
pLI50
pLI50 derivative containing htsABC from S.
pEV55
(7)
aureus; CmR
(17)
Temperature-sensitive S. aureus suicide vector;
pAUL-A
EmR L cr
(153)
E. coli cloning vector; ApR
pUC19
(58)
pET28a(+) derivative encoding SfaB; KmR
pJDC41
(58)
pET28a(+) derivative encoding SfaD; KmR
pJDC42
(59)
pMTL22 derivative that carries a Tc resistance
pDG1513
cassette; ApR
aAbbreviations:
i_
_ R A„_R
_R _
R _
______________________ : _____
KmR, ApR
, CmR, EmR,
and LcR,
resistance
to kanamycin, ampicillin, chloramphenicol,
a

I

.

..

ft

A

t

-

J T

erythromycin, and lincomycin, respectively.
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2.2.2. Plasmid isolation from S. aureus
Plasmid DNA was isolated from S. aureus as described for E. coli, but with the
following modifications. Approximately 1 mL of stationary phase S. aureus culture was
harvested by centrifugation (10 000 x g) and resuspended in 250 pL of PI buffer that
was modified by the addition of 50 pg mL'1 lysostaphin (Sigma). Cells were then
incubated at 37°C for 30 minutes prior to addition of P2 buffer.

2.2.3. Restriction enzyme digests
Restriction endonucleases were purchased from Roche Diagnostics or New
England Biolabs (NEB) and reactions were completed according to the manufacturer’s
instructions. Typically, reactions were completed in 20 pL and incubated for 1 hour at
37°C. The resulting DNA fragments were then cleaned using the QIAquick PCR
purification kit (QIAgen) according to the manufacturer’s instructions.

2.2.4. DNA ligations
T4 DNA ligase was purchased from Roche Diagnostics or NEB and reactions
were completed according to the manufacturer’s instructions. Typically, reactions were
completed in 20 pL, with a 3:1 insert to vector DNA ratio, and incubated overnight at
4°C.
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2.2.5. Agarose gel electrophoresis
Agarose gel electrophoresis was used to separate, visualize, and quantify DNA
fragments. Agarose gels consisted of 0.8% w/v agarose in TAE buffer (40 mM Trisacetate, 1 mM EDTA), supplemented with 1 pL SYBR Safe DNA gel stain (Invitrogen).
Prior to loading, DNA samples were mixed with loading buffer (5% v/v glycerol, 0.04%
w/v bromophenol blue, 0.04% w/v xylene cyanol, 10 mM EDTA, pH 7.5) in a 5:1 DNA
to buffer ratio, and 12 pL was loaded per well. The gels were run at 110 V for 20
minutes and a 1 kb-Plus ladder (Invitrogen) was used as a standard reference for
estimating DNA size. After electrophoresis, gels were placed on a ChemiDoc XRS unit
and DNA was visualized using Quantity One software (Bio-Rad).

2.2.6. In-well cell-lysis plasmid screening
In-well cell-lysis was used to rapidly screen E. coli for the presence of
recombinant plasmid DNA. In summary, a 0.8% w/v TBE-agarose gel was
supplemented with 0.4% w/v SDS prior to solidification and immersion in TBE buffer.
A toothpick was then used to harvest a small quantity of E. coli cells from an agar plate
that were resuspended in 10 pL of sterile water and 10 pL of SRL buffer (1 mg mL 1
lysozyme, 25% w/v sucrose in TBE, and 10 pgmL"1 RNase A). Ten microlitres of each
suspension was then loaded per well and allowed to incubated for 10 minutes at room
temperature or until lysis was complete. The gels were then run at 20 V for 20 minutes,
followed by 105 V for 30 minutes. The gels were then stained with ethidium bromide
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(EtBr) and placed on a ChemiDoc XRS unit and DNA was visualized using Quantity
One software (Bio-Rad).

2.2.7. Isolation of DNA fragments from agarose gels
Following electrophoresis, desired DNA fragments were visualized and
identified under UV light (365 nm) and excised from agarose gels using a glass cover
slip. The DNA fragments were then isolated using the QIAquick Gel Extraction Kit
(Qiagen), according to manufacturer’s instructions.

2.2.8. Isolation of chromosomal DNA from S. aureus
S', aureus Newman chromosomal DNA was obtained using the InstaGene Matrix
(Bio-Rad) as described by the manufacturer. Typically, 1 pL of the resulting
chromosome supernatant was used as template DNA in polymerase-chain reactions
(PCR).

2.2.9. Polymerase-chain reaction
PCRs were completed in 50 pL reactions containing template DNA, lx PCR
buffer (Roche Diagnostics), 200 pM dNTP (Roche Diagnostics), 12 picomoles of
forward and reverse primers (IDT DNA), and 2.5 units of Pwol DNA polymerase
(Roche diagnostics). PCRs were performed using the GeneAmp PCR system (PerkinElmer), the PTC-200 Peltier Thermal Cycler (MJ Research Inc.), or the MJ Mini™
Personal Thermal Cycler (Bio-Rad). Oligonucleotide primers are listed in Table 4.
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Table 4. Oligonucleotides used in this study
Sequence"
Purpose
5 ’-AAGCT AGC ACTATTT CGGT AA A AG AT GA AAAT G-3 ’
Cloning of htsA
(forward, Nhel)
(Soluble Portion)
5 ’-AAGG AT CCC ATTT ACTTCC ACCTT ACTTTT GTT C-3 ’
Cloning of htsA
(reverse, BamHT)
—
(Soluble Portion)
Cloning of htsABC 5 ’-T GAGCT CTGCGATT AC ATT GGAGGCT G-3 ’
(forward, Sacl)
(from S. aureus)
Cloning of htsABC 5 ’-TGCCCGGGGTT AGTT ATTT CATT CTTCG-3 ’
(reverse, Smal)
(from S. aureus)
5 ’-TAAGCT AGC AT GGTATAT CTT GAAT GGGC-3 ’
Cloning of sfaB
(forward, Nhel)
(from S. aureus)
5 ’-TAT GG AT CCCTAC ACCT CTTTTTTTAT CG-3 ’
Cloning of sfaB
(reverse, BamHl)
(from S. aureus)
5 ’-GCCGCTAGCATGAACTTGAAC-3 ’
Cloning of sfaD
(forward,
Nhel)
(from S. aureus)
5 ’-TCT GG AT CCTTAATT ATTTTCTCG AT AC AAAG-3 ’
Cloning of sfaD
(reverse, BamHT)
(from S. aureus)
° Restriction sites for cloning of PCR products are underlined.
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2.2.10. Site-directed mutagenesis
Site-directed mutagenesis was carried out using the QuickChange® site-directed
mutagenesis kit (Stratagene), using Pfu Turbo® DNA polymerase, or Phusion® DNA
polymerase (New England Biolabs). Following amplification, DNA was treated with
Dpnl endonuclease (New England Biolabs) to degrade template DNA. Remaining DNA
was vacuum-centrifuged to a volume of approximately 20 pL prior to transformation of
E. coli DH5a CaCl2 competent cells and plating on selective media. Primers were
ordered from IDT DNA and are listed in Table 5.

Table 5. Oligonucleotides used for site-directed mutagenesis_________________
Purpose____________________ Sequence"_____________________________________________
Mutation o f HtsA, R104A
5 ’-G ATTATACTTCTGTAGGTACAGCTAAACAGCC-3 »
(forward)
5 ’-CTTCTAAGTTTGGCTGTTTAGCTGTACCT-3’ (reverse)
Mutation o f HtsA, R104A
5 ’-CC A A ACTT AGÇAG A A ATT AGT A A ATT A A A AC-3 ’
Mutation o f HtsA, E l 10A
(forward)
5 ’-CCGGTTTT A ATTT ACTA ATTTCTGCT A AGTTT G-3 ’
Mutation o f HtsA, E l 10A
(reverse)
5 ’-G ATTT A ATTATCGCTG ATAGCAGTGCAC AT-3 ’
Mutation o f HtsA, R126A
(forward)
5 ’-TATTAATACCTTTATGTGC ACTGCTATC AGC-3 ’
Mutation o f HtsA, R126A
(reverse)
5 ’-CTTCC AGC AGTAGTTGCTGÇAGCTG-3 ’ (forward)
Mutation o f HtsA, K203A
5 ’-G ATGTGCT A AT AAACC AGCTGC AGCA-3 ’ (reverse)
Mutation o f HtsA, K203A
5’-GCTAAAGCTGGTTTATTAGCAGCTCCA-3 * (forward)
Mutation o f HtsA, H209A
5 ’-GTCCAACATATGAATAGTTTGGAGÇTGCT-3’ (reverse)
Mutation o f HtsA, H209A
5 ’-CG ATGTA AC A AA AGGTTTAAGTAA AGÇTTTG A-3 ’
Mutation o f HtsA, Y 239A
(forward)
5 ’-AGTAAGGTCCTTTC AAAGÇTTTACTTAAACC-3 ’
Mutation o f HtsA, Y239A
(reverse)
5 ’-CTTACTTAC AATTAGACACTGÇAC ATTT AGC-3 ’
Mutation o f HtsA, E250A
(forward)
5 ’-C AGCTAAATGTGCAGTGTCTAATTGTAAG-3 ’ (reverse)
Mutation o f HtsA, E250A
5 ’-GTCGATGATGGTAAGAAAAAAAAAATC-3’ (forward)
Mutation o f HtsA, R86K
5 ’-CTCTAACTGGTTTAATGATTTTTTTTTTC-3’ (reverse)
Mutation o f HtsA, R86K
5 ’-GATT AT ACTTCTGTAGGTACAA A AAAACAGCC-3 ’
Mutation o f HtsA, R104K
(forward)
5 ’-CTTCTAAGTTTGGCTGTTTTTTTGTACCT-3’ (reverse)
Mutation o f HtsA, R104K
5 ’-TCGCTG AT AGC AGT A AAC AT AAAGGT A-3 ’ (forward)
Mutation o f HtsA, R126K
5’CTTTATTAATACCTTTATGTlTACTGCTATCAGC-3’
Mutation o f HtsA, R126K
(reverse)
5 ’-CC AGC AGTAGTTGCTAGAGCTGGTT-3’ (forward)
Mutation o f HtsA, K203R
5 ’-G ATGTGCTAAT AAACC AGCTÇTAGC A ACT A-3 ’
Mutation o f HtsA, K203R
(reverse)
5 ’-GCTAAAGCTGGTTTATTAGCACAACCA-3 ’ (forward)
Mutation o f HtsA, H209Q
5 ’-GTCCAACATATGAATAGTTTGG1TGTGCT-3 ’ (reverse)
Mutation o f HtsA, H209Q
5 ’CG AT GTA AC A A A AGGTTT A AGT A A ATTTTT G A-3 ’
Mutation o f HtsA, Y239F
(forward)
Mutation o f HtsA, Y239F
5 ’-AGT AAGGTCCTTTC AAAAATTTACTT AAACC-3 ’
(reverse)
Mutated bases are underlined.
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2.2.11. DNA sequencing
DNA sequencing was provided by the DNA Sequencing Facility of the Robarts
Research Institute (London, Ontario) or the York Sequencing Facility (Toronto, Ontario).

2.2.12. Computer analysis
DNA sequence analysis, oligonucleotide primer design, and protein analysis
were completed using Vector NTI Suite software package (Informax, Bethesda, MD).
Data was analyzed using Microsoft Office Excel and graphs were generated using
GraphPad Prism 4.0.

2.3. Transformation methodologies
2.3.1. Preparation of transformation competent E. coli
E. coli DH5a CaCl2 competent cells were prepared as follows: An overnight,
stationary phase DH5a culture was normalized to an OD6 0 0 of 1, diluted 1:100 into 500
mL of fresh LB, and grown to an ODeoo of approximately 0.5. The culture was then
placed on ice for 30 min and cells were harvested by centrifugation at 5 000 x g. The
cells were then resuspended in 100 mL of CaCl2 solution (100 mM CaCl2, 15% glycerol)
and incubated on ice for 30 min. Cells were harvested again by centrifugation,
resuspended in 4 mL of CaCl2 solution, and aliquots of 100 pL were stored at -80°C.
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2.3.2. Transformation of CaCh competent.#, coli
Purified plasmid DNA or ligation reactions were added to an aliquot of E. coli
DH5a CaCb competent cells and kept on ice for 30 min. Cells were then subjected to
heat shock treatment at 42°C for 2 min followed immediately by 2 min incubation on ice.
The cells were resuspended in 900 pL of fresh LB, mixed by inversion, and incubated
for 1 h at 37°C prior to plating on selective media and incubation overnight.

2.3.3. Preparation of transformation competent & aureus
Strains of S. aureus were made electro-competent as follows: An overnight,
stationary phase culture of S. aureus was normalized to an ODeoo of 1, diluted 1:100 into
400 mL of fresh TSB, and grown to an OD6 0 0 of approximately 0.4. The cells were then
harvested by centrifugation at 5 000 x g and resuspended in an equal volume of 500 mM
sucrose and incubated on ice for 30 min. The cells were then harvested by centrifugation
and resuspended in 4 mL of 500 mM sucrose. The last step was reeated and aliquots of
60 pL were stored at -80°C.

2.3.4. Transformation of electro-competent S. aureus
Purified plasmid DNA was added to an aliquot of electro-competent S. aureus
cells and kept on ice for 30 min. Cells were then transferred to an ice-cold
electroporation cuvette (2 mm, Bio-Rad) for electroporation. Electroporation was
performed using a Bio-Rad Gene Pulser II with the following settings: 2.5 V, 200 mA,
and 25 Q. Pulsed cells were then resuspended in 900 pL of fresh TSB, transferred to a
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sterile micro-centrifuge tube, and incubated for 1 h at 37°C prior to plating on selective
media and incubation overnight.

2.4. Mutagenesis and DNA cloning methodologies
2.4.1. Mutagenesis of htsABC
The construction of a S. aureus Newman strain bearing an htsABC::Tc operon
deletion has been previously described (7). For complementation, the htsABC locus and
flanking promoter region was PCR amplified from S. aureus Newman chromosomal
DNA and the 4.0-kb fragment was cloned into pLI50, generating pEV55 as illustrated in
Figure 6. Oligonucleotide primers used are listed in Table 4.

2.5. Siderophore synthesis, purification, quantification
2.5.1. Staphyloferrin A synthesis
Using rSfaB and rSfaD, in vitro SA biosynthesis was carried out as previously
described (27), with minor modifications. Briefly, reactions were completed in 500 pL
containing 1 mM sodium-citrate, 1 mM D-omithine, 5 mM ATP, 0.5 mM MgCh, 50
mM HEPES, 5 pM rSfaB, and rSfaD at pH 7.4, and incubated for 12 hours in the dark at
room temperature.

Figure 6. Physical maps of plasmids pEV99 and pEV55. For pEV99, a fragment
containing the soluble potion of the htsA coding region was cloned into the pET28a(+)
protein overexpression vector between the BamHl and NheI restriction sites. The
plasmid also contains a pBR233 origin of replication that allows for replication in Gram
negative bacteria, a la d region that encodes for a Lac repressor protein. For pEV55, a
fragment containing the upstream regulatory sequence and the htsABC operon was
cloned into the E. coli/S. aureus shuttle vector, pLI50, between the S a d and Smal
restriction sites. The plasmid also contains an ApR marker (bla) for selection in E. coli
and a CmR marker (cat) for selection in S. aureus. The plasmid also contains two origins
of replication, pBR233 and RepB, which allow for replication in Gram-negative and
Gram-positive bacteria, respectively.
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2.5.2. Staphyloferrin A purification
Following incubation, SA was purified from reactions as described (58). Briefly,
enzymes were removed via centrifugation in an Amicon® Ultra-0.5 10k filter column
(Millipore) at 14 000 x g for 15 minutes. The filtrate was supplemented with 3 mM
FeCfi and centrifuged at 18 000 x g to remove precipitate. Fifty microlitres of the
resulting solution was injected onto a Waters xTerra C l8 reversed-phase 5-pm column
(150 mm x 2.1 mm) on a Beckman System Gold HPLC equipped with a photodiode
array detector. The samples were run at 0.2 mL/min using a step gradient as previously
described (27), with minor modifications. In summary, solvent B was 10 mM
tetrabutylammonium phosphate, pH 7.3, in HPLC grade water (Fisher), and solvent A
was 100% acetonitrile (Fisher). The step gradient consisted of a 2 min hold at 85% B, a
1 min ramp and 4 min hold at 72% B, a 1 min ramp and 3.5 min hold at 66% B, and a 1
min ramp and 3 min hold at 20% B. Peaks were monitored at 340 nm and data were
analyzed using the 32 Karat Software Version 8.0 system. The peak corresponding to
Fe-SA eluted at 17 min and was collected using the Beckman SC 100 fraction collector,
vacuum-centrifuged to dryness, and resuspended in deionized water.

2.5.3. Staphyloferrin A detection
The presence of SA following in vitro synthesis was confirmed using chrome
azurol S (CAS) shuttle solution (133), as previously described (32). Briefly, dilutions of
SA reactions were mixed with equal volumes of CAS shuttle solution and incubated for
45 min in the dark at room temperature. SA presence was verified through determination
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of siderophore units by the following formula: [(A630 of control reaction (missing ATP)
- A630 of sample)/(A630 of control reaction)(inverse of dilution factor)] x 100%.
The presence of Fe-SA following ion-pair HPLC purification was confirmed
using liquid chromatography/mass spectrometry (LC/MS) as previously described (27),
with minor modifications. In summary, EDTA was added to Fe-SA samples to increase
SA detection sensitivity in the LC-MS (97).

2.5.4. Staphyloferrin A quantification (AAS)
Atomic absorption spectroscopy was used to indirectly determine the
concentration of Fe-SA by measuring the concentration of iron in the HPLC-purified FeSA samples as previously described (58). Briefly, Fe-SA samples were diluted in 1 M
nitric acid and then drawn by an SPS 5 sample preparation system (autosampler) into a
Varian AA240 atomic absorption spectrometer. An iron/manganese hollow cathode
lamp was used to detect iron absorbance by emitting at 248.3 nm. Calibration standards
were analyzed to generate a linear calibration curve. The curve was generated using
known iron standards, diluted in 1 M nitric acid, from an atomic absorption spectrometer
certified 1000 ppm ± 1% stock (Fisher) before the Fe-SA samples were analyzed.

2.6. S. aureus growth curves
Bacteria were cultured for 12 h in TMS broth followed by an additional 12 h in
fresh TMS broth. Cells were washed three times with 0.9% w/v saline and diluted 1:100
into 80% horse serum (Sigma-Aldrich) and 20% Chelex® 100 resin (Bio-Rad) treated
TMS broth. For iron replete media, 50 pM FeCl3 was added. Cultures were grown with
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constant, medium amplitude shaking in a Bioscreen C machine (Growth Curves, USA)
and OD was measured at 600 nm every 30 min.

2.7. Disk-diffusion growth assays
The ability of Fe-SA to promote the iron-restricted growth of S. aureus Newman
AsirAAhtsABC harbouring plasmid-borne WT or mutant htsABC was determined using
disk-diffusion assays as previously described (7), with minor modifications. In summary,
S. aureus cells were inoculated into TMS agar containing 10 pM EDDHA to achieve 1 x
104 cells mL'1. Desferrioxamine (50 pM) was used as a positive control for growth. Ten
microlitres of SA or Desferrioxamine were added to sterile paper disks which were then
placed onto the plates. Growth diameter was measured after 24 h at 37°C.

2.8. Protein methodologies
2.8.1. Protein purification
The SA synthetases, SfaB and SfaD, and the SA-receptor, HtsA, were purified
for use in SA synthesis reactions and Fe-SA fluorescence titration experiments,
respectively. A rHtsA overexpression vector constructed as described (7, 58) was used
to express and purify rHtsA from E. coli ER2566 as previously described (7). Briefly,
DNA encoding a portion of mature HtsA (residues 38-327), was PCR amplified from S.
aureus Newman chromosomal DNA and the 1-kb fragment was cloned into pET28a(+),
generating pEV99 as illustrated in Figure 6. The sfaB and sfaD coding regions were
amplified from S. aureus Newman chromosomal DNA and cloned into pET28a(+) for
over-expression in E. coli BL21(DE3) as previously described (58). In summary,
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cultures were grown in LB (Difco) supplemented with 30 qg/mL Km at 37°C. At an
ODöooof ~0.9 isopropyl 1-thio-ß-D-galactopyranoside (IPTG) (500 qM) was added and
the culture was incubated for an additional 18 h at room temperature with shaking (180
rpm).
Cells were harvested by centrifugation at 15 000 x g, resuspended in binding
buffer (50 mM HEPES, 500 mM NaCl, 10 mM imidazole at pH 7.4), and passed three
times through a French pressure cell at 1500 p.s.i. Cell lysate was centrifuged at 15 000
x g to remove unbroken cells and debris and the supernatant was centrifuged at 150 000
x g for 1 h to precipitate insoluble material. The soluble fraction was applied to a 1-mL
His-Trap nickel affinity column (GE Healthcare) equilibrated with binding buffer (50
mM HEPES, 150 mM NaCl, 10 mM Imidazole, pH 7.4), and His6-tagged proteins were
eluted with a gradient of 0-80% elution buffer (50 mM HEPES, 150 mM NaCl, 500 mM
Imidazole, pH 7.4). Proteins were then dialyzed into 50 mM HEPES, 150 mM NaCl, and
10% glycerol, pH 7.4, at 4°C. Protein purity was confirmed using SDS-polyacrylamide
gel electrophoresis (see the following section) and 100-pL aliquots were frozen at -80°C.

2.8.2. Protein quantification
Protein concentrations were determined using a Bradford protein assay or
spectrophotometric A 2 8 0 assay for experiments and reactions or CD measurements,
respectively. Protein yields for rSfaB, rSfaD, and WT or mutant rHtsA were 6.8, 25, and
-50 mg L '1, respectively.

2.8.3. SDS-polyacrylamide gel electrophoresis
Proteins, whole-cell lysates, or resuspended detergent pellets were diluted 3:1
with a protein loading buffer (10% glycerol, 64 mM Tris, 2% SDS, 5% (3mercaptoethanol, and 0.01% bromophenol blue, pH 6.8) and boiled for 10 min prior to
SDS-polyacrylamide gel electrophoresis, following standard protocols (127). Briefly,
SDS-polyacrylamide gels consisted of a 5% acrylamide (Bio-Rad) stacking gel, 12%
acrylamide (Bio-Rad) resolving gel, and were run at 130 V for 1.5 h. Proteins were
stained with Coomassie Brilliant Blue R-250 using standard procedures. Gels were then
visualized under white light, scanned using a CanoScan LiDE 700F, and illustrated
using Adobe Photoshop CS2.

2.9. Western blotting methodologies
2.9.1. S. aureus whole cell lysate preparation
S. aureus cells were grown overnight in TMS media, diluted into fresh TMS, and
grown for an additional 12 h. The cells were then washed three times with 0.9% w/v
saline, equilibrated to an ODeoo of 1.2, and 100 pL were harvested via centrifugation (10
000 x g) for 1 min. The pellets were then resuspended in 100 pL digestion buffer (30%
w/v raffmose, 50 mM Tris, 145 mM NaCl, 10 pM phenylmethylsulfonyl fluoride, 50 pg
mL'1 lysostaphin (Sigma), “pinch” iodoacetamide, and 20 pg m L'1 DNAse, pH 7.5) and
incubated for 45 minutes at 37°C or until lysis was achieved.

i
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2.9.2. Detergent partitioning of membrane proteins
S. aureus cells were grown overnight in TMS media, diluted into fresh TMS, and
grown overnight to late-log-phase. The cells were then harvested by centrifugation (10
000 x g), washed three times with 0.9% w/v saline, and equilibrated to an OD6 0 0 of 1.0
in PBS. The cells were then supplemented with 50 pg mL'1 lysostaphin, incubated at
37°C for 15 min, and diluted with 900 pL of PBS. Detergent extraction and phase
partitioning was completed as previously described (25). In summary, cells were
sonicated twice on a Branson Digital Sonifier® (Branson Ultrasonics Corporation,
USA) fitted with a 3-mm-diameter probe, and cooled on ice. 10% v/v Triton X-l 14 in
PBS was then added and each sample was incubated for 2 h at 4°C. Samples were then
centrifuged (13 000 x g) at 4°C for 10 min to pellet insoluble debris. The supernatants
were transferred to clean microcentrifuge tubes, incubated at 37°C for 30 min, and
centrifuged (13 000 x g) for 10 min at room temperature to pellet the detergent phase.
The aqueous phase was then removed and the detergent pellet was washed with 1 mL
PBS at 4°C for 1 h, transferred to 37°C for 30 min, repelleted, and diluted 1:1 in
deionized water for solubilization.

2.9.3. Generation of anti-HtsA antisera
Rabbit polyclonal antibodies recognizing rHtsA were generated by ProSci
(Poway, CA) using custom anti-body production package 1 protocol.
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2.9.4. Western Blotting
Following SDS-polyacrylamide electrophoresis, proteins were transferred to a
BioTrace™ NT nitrocellulose membrane (Pall Life Sciences) at 250 mA for 1 h. The
membranes were then transferred to a clean container, 30 mL of blocking buffer (10%
v/v horse serum (Sigma) and 10% w/v skim milk) was added, and they were incubated
overnight at 4°C with gentle shaking. Blocking buffer was then removed, 25 mL of a
primary antibody solution (1/5000 dilution of primary antisera, 5% v/v horse serum
(Sigma), and 2.5% w/v skim milk) was added, and they were incubated for 2 h at 4°C
with gentle shaking. The primary antibody solution was then removed and the
membranes were washed three times in ~25 mL TBS buffer (20 mM Tris and 150 mM
NaCl, pH 7.5) for 10 min. 25 mL of a secondary antibody solution (1/7500 1 mg mL'1
anti-rabbit IgG (H&L) (GOAT) Antibody IRDye800® Conjugated (Rockland), 5% v/v
horse serum (Sigma), and 2.5% w/v skim milk) was added, and they were incubated for
1 h at 4°C with gentle shaking. The secondary antibody solution was then removed and
the membranes were washed three times in ~25 mL of TBS buffer supplemented with
0.05% Tween-20 for 10 min. Membranes were then scanned on a Odyssey Infrared
Imager (Li-Cor) and visualized using Odyssey V3.0 software (Li-Cor).
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2.10. rHtsA-SA fluorescence spectroscopy
The rHtsA-SA dissociation constant (Kd) was determined using fluorescence
spectroscopy as described (58). In summary, fluorescence titration experiments were
performed at room temperature using 15 nM rHtsA in 50 mM HEPES, pH 7.4, in a
Fluorolog-3 spectrofluorometer (ISA Instruments) across a Fe-SA range of 0.22 and 226
nM. Excitation and emission slits were set at 2.1 and 6.3 nm, respectively, and the
excitation and emission wavelengths were set at 280 and 334 nm, respectively. R values
and relevant parameters were calculated by fitting the fluorescence data to a one-site
binding model accounting for ligand depletion and data were analyzed by nonlinear
regression analysis using the solver tool add-in from Microsoft Office® Excel software
as previously described (134, 135).

2.11. Circular dichroism
Proteins were dialysed into a solution of 10 mM sodium phosphate and 150 mM
sodium fluoride, pH 7.4, and normalized to a concentration where the A2 8 0 was ~0.2.
Circular dichroism (CD) measurements were obtained using a J-810 spectropolarimeter
(Jasco) with the following settings: standard sensitivity, 260-190 nm measurement range,
0.5 nm data pitch, continuous scanning, 10 nm/min scanning speed, 1 nm bandwidth,
and 5 accumulations per sample. Measurements were completed in a 1mm quartz
cuvette and data was analyzed using Microsoft Office Excel. The CD signal (6, in
millidegrees) was converted to mean residue ellipticity (MRE) {[6\, in deg cm2/dmol)
using the equation [d\ = d x MRE/10

y.

C x i , where MRE = MW In, prior to graphing.

Chapter 3 - Results
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3.1. HtsA has a unique Fe-SA binding pocket
At the start of this project we had just obtained the holo-structure of Fe-SArHtsA as illustrated in Figure 5. rHtsA is a class III substrate binding protein and has in
common the overall protein fold embodied by other members of this protein family.
However, the structure informed us that it used a novel form of ligand entrapment (i.e.
many positively charged residues) to bind Fe-SA (58). In order to investigate the Fe-SArHtsA binding specificity and affinity, and to meet the objectives as outlined above, I
needed to prepare sufficient quantities of Fe-SA and rHtsA.

3.2. In vitro synthesis of staphyloferrin A
Near the beginning of my project, Cotton et al. demonstrated that SA could be
synthesized in vitro using recombinant SfaB and SfaD synthetases, along with citric acid
and D-omithine as substrates (27). This confirmed the SA biosynthesis pathway
illustrated in Figure 3. For the purposes of my project goals, rSfaB and rSfaD were
overexpressed and purified. The purity and integrity of the rSfaB (69.4 kDa) and rSfaD
(78.2 kDa) is demonstrated in Figure 7. SA synthesis reactions were set up as described
(27). The ion-pair HPLC chromatogram illustrated in Figure 8 demonstrated that only
the complete reaction generated a peak that corresponds to Fe-SA (27). Furthermore,
CAS shuttle solution (133) was used to quickly assess the iron-binding activity of SA
and, in agreement with previous findings, only complete SA synthesis reactions tested
positive with CAS shuttle solution (133) (i.e. omitting either enzyme or any reaction
component resulted in no siderophore activity).

Figure 7. rSfaB, rSfaD, and rHtsA proteins were purified. Coomassie stained SDSpolyacrylamide gel showing purified his-tagged rSfaB, rSfaD, and rHtsA.
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Figure 8. Ion-pair HPLC analysis of in vitro staphyloferrin A production. Missing
reaction components are indicated on each trace. Reactions were monitored at 340 nm
(see Materials and Methods).
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SA had to be further purified from the in vitro synthesis reactions for use in FeSA-rHtsA binding assays. In order to obtain purified Fe-SA, ion-pair HPLC was used to
separate the in vitro SA synthesis reaction components, and the fractions containing the
SA peak were collected (Fig. 9A). LC/MS of the collected fractions and in vitro
synthesis reactions detected SA at an m/z =479 in both samples, consistent with previous
studies (27, 58). As illustrated in Fig. 9B, collection of ion-pair HPLC SA fractions
reduces the amount of reaction contaminants present. Eight reaction mixtures, set up as
described in the Materials and Methods section, were run across the HPLC column,
yielding 4 mL o f —120 pM Fe-SA (data not shown).

Figure 9. Fe-SA can be separated and purified from reaction components using ion-pair
HPLC. A) Ion-pair HPLC trace showing the Fe-SA peak eluting at 17.5 min, ahead of
reaction components, which elute at 20 min. B) LC/MS demonstrating that Fe-SA
fractions are purified from other reaction components. C) LC/MS of unpurified Fe-SA
biosynthesis reactions. The reaction was monitored at 340 nm.
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3.3. rHtsA has high affinity for Fe-SA
Previous studies demonstrated that rHtsA is soluble, stable, and expresses well in
E. coli BL21(DE3) (7, 58). Furthermore, the holo-crystal structure demonstrated that
rHtsA could bind Fe-SA out of concentrated culture supernatants (58). As described in
the methods section, plasmid pEV99 was used to overexpress rHtsA in E. coli and the
protein was purified. The purity and integrity of the rHtsA (35.2 kDa) is demonstrated in
Figure 7.
Changes in the intrinsic fluorescence of rHtsA were measured following ligand
(Fe-SA) titration to determine the Fe-SA-rHtsA binding affinity (58). Saturating
concentrations of Fe-SA caused an average 52.5% reduction of rHtsA fluorescence
emission. The Fe-SA-rHtsA Kd was in the low nM range (~1.0 +/-0.3 nM) however; the
value could not be determined accurately because the concentration of rHtsA (15 nM)
used was greater than the Kd (Fig. 10), resulting in ligand depletion. The specificity of
rHtsA for Fe-SA was demonstrated by the fact that another staphylococcal ahydroxycarboxylate siderophore, Fe-SB, synthesized and purified as previously
described (7), did not quench the intrinsic fluorescence of rHtsA (data not shown).

Figure 10. Saturation curve of the binding of Fe-SA to HtsA. rHtsA was titrated with
increasing concentrations (as determined by atomic absorption spectroscopy) of Fe-SA
and intrinsic fluorescence knockdown is depicted here as percent saturation. The
experimental data is represented as the solid line with diamonds and the theoretical data
(predicted by non-linear regression, one-site binding model) is the dashed line. Inset
represents an emphasis in the region of Fe-SA concentrations used to determine the
dissociation constant. Data is the result of three independent experiments using different
batches of HtsA and error bars represent standard deviation from the mean.
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3.4. Amino acid substitutions do not affect overall protein fold of rHtsA
The Fe-SA-rHtsA crystal structure identified several rHtsA residues that formed
contacts with Fe-SA (Fig. 5C). As outlined in the objectives, one of my goals was to
determine the significance of those residues for productive binding in vitro. To
investigate the role of each residue found to interact with SA, site-directed mutagenesis
on pEV99 was used to substitute each interacting residue with either alanine or an amino
acid with more conserved properties. Using the same strategy described earlier, rHtsA
mutant derivatives were overexpressed and purified from E. coli BL21(DE3). No
problems with solubility, stability, or expression of any of the proteins used in this study
were encountered. The purity and integrity of the proteins is demonstrated in Figure 11.
In order to confirm that any reductions of Fe-SA binding affinity caused by
mutation of rHtsA were not indirectly due to decreased structural integrity, CD spectra
of each rHtsA protein were measured and compared to WT rHtsA. All proteins had an
a-helical emission profile characteristic of class III binding proteins and none of the
mutations I constructed in rHtsA resulted in any significant difference in the CD spectra
compared to WT protein (Fig. 12).

Figure 11. WT and mutant rHtsA proteins were purified. Coomassie stained SDSpolyacrylamide gel showing purified his-tagged WT and mutant rHtsA.
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Figure 12. Point mutations do not result in gross rHtsA conformational changes.
Circular dichroism spectra of WT and mutant rHtsA proteins indicate a proper a-helical
conformation. Spectra were analyzed across wavelengths of 260 to 190 run. MRE, mean
residue ellipticity.
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3.5. HtsA R104A, R126A, and H209A have reduced Fe-SA-rHtsA binding affinity
Using the approach described earlier, the effect that each mutation had on the FeSA-rHtsA Kd was determined (Table 6). R104A and R126A mutations resulted in the
greatest reductions of binding affinity, failing to reach saturating levels of rHtsA
fluorescence quenching at all concentrations of SA tested (>1.3 pM). H209A also had a
significantly reduced binding affinity, failing to saturate rHtsA fluorescence quenching
at all concentrations of SA tested as well (>10 pM). However, upon addition of ~1.2 pM
Fe-SA, the fluorescence emission of H209A was reduced 24.9%, whereas R104A and
R126A were only reduced 8% and 13%, respectively. This suggests that the H209A
rHtsA mutant binds SA with greater affinity than the R104A or R126A rHtsA mutants.
Also, the R104K mutation resulted in a ~700-fold decrease in binding affinity.

Table 6. Effect of rHtsA mutations on binding affinity
Protein
Ligand“
Dissociation
(rHtsA)
Constant (Ka)b
WT
Fe-SA
0.91±0.34nM
Fe-SB
DNB°
WT
1.37±0.42nM
R86K
Fe-SA
R104A
Fe-SA
DNBC
R104K
Fe-SA
723±231 nM
E110A
Fe-SA
NDd
R126A
Fe-SA
DNB°
R126K
Fe-SA
1.00±0.03nM
K203A
Fe-SA
5.23±2.19nM
Fe-SA
5.07±1.11 nM
K203R
DNBC
H209A
Fe-SA
Fe-SA
2.01±0.23 nM
H209Q
2.36±0.11 nM
Y239A
Fe-SA
2.60±0.02 nM
Y239F
Fe-SA
E250A
Fe-SA
1.18±0.17 nM
NDd
E110/250A Fe-SA
aLigands are ferrated prior fluorescence titrations.
b Values represent averages and ± denotes standard deviation, n=3.
c DNB, does not bind; no fluorescence saturation when [siderophore] > 1 pM.
J ND, not determined.
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3.6. HtsABC is required for Fe-SA uptake
Previously, Beasley et al. demonstrated that HtsABC is required for the transport
of Fe-SA using two separate assays (7). Additionally, it was demonstrated that
chromosomal deletion of htsABC in S. aureus Newman in the absence of Fe-SB uptake
results in a drastic reduction of growth under iron-restricted conditions (7). Using similar
strategies, one of my major objectives was to determine the significance of each HtsA
residue identified earlier for productive transport in vivo.
In order to do this, I first needed a vector that could complement the S. aureus
Newman AhtsABC associated growth reduction. Importantly, Beasley et al. also
demonstrated that growth could be rescued via complementation with pEV55, an E.
colHS. aureus shuttle vector containing the S. aureus htsABC operon and promoter
region (7). To investigate the role of each residue found to interact with SA in vivo, sitedirected mutagenesis on pEV55 was used to substitute each interacting residue with
either alanine or an amino acid with more conserved properties.

3.7. S. aureus expresses recombinant HtsABC
Although previous studies demonstrated that plasmid-borne HtsABC could
complement S. aureus Newman AhtsABC, I needed to confirm proper expression of the
mutant derivatives of HtsA. In order to verify this, Western immunoblots against HtsA
were completed in whole cell lysates of S. aureus Newman AhtsABC harboring WT or
mutant pEV55. As illustrated in Figure 13, all pEV55 constructs resulted in similar HtsA
expression levels.

Figure 13. WT and mutant HtsA express well in S. aureus Newman. Western
immunoblots using anti-HtsA antiserum were completed on whole-cell lysates of S.
aureus Newman. WT and mutant derivatives express similar amounts of HtsA. No HtsA
is detected in the S. aureus mutant carrying empty vector.

82

83

3.8. S. aureus HtsA localizes to the extracellular membrane
HtsA is a class III substrate binding protein that is tethered to the extracellular
face of the cytoplasmic membrane via N-terminal lipidation. There, it functions as the
Fe-SA-receptor before docking to its cognate permeases, HtsBC. In order to confirm that
any growth deficits caused by mutation of HtsA were not indirectly due to altered
protein expression and/or localization, Western immunoblots against HtsA were
completed in detergent extracted membrane fractions of S. aureus harboring WT or
mutant pEV55. As illustrated in Figure 14, all pEV55 constructs resulted in expression
of HtsA that was localized to the cytoplasmic membrane.

Figure 14. WT and mutant HtsA localize to the cell membrane of S. aureus Newman.
Western immunoblots using anti-HtsA antiserum were completed on detergent extracted
membrane fractions from S. aureus Newman. No HtsA is detected in the S. aureus
mutant carrying empty vector.
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3.9. Substitution of HtsA R104A, R126A, or H209A reduces Fe-SA-dependant
growth of S. aureus in iron-restricted liquid growth media
In order to determine the significance of each HtsA residue substitution for
productive transport in vivo, I generated iron-restricted growth curves of S. aureus
Newman AhtsABC harboring WT or mutant derivatives of pEV55. As illustrated in
Figure 15, substitution of HtsA R104A or R126A resulted in drastic growth reductions
and substitution o f HtsA H209A severely delayed growth. Importantly, these results
agree with the binding affinity data which indicated that HtsA with substitutions R104A,
R126A and H209A had severe reduction in ligand binding. Interestingly, although HtsA
R104K had a 700-fold higher Kd for Fe-SA than WT HtsA, S. aureus harbouring this
HtsA mutation was not debilitated for SA-dependent growth. All growth deficits were
rescued by the addition of 50 p,M F e C f, a growth condition that eliminates the
requirement for Fe-SA for growth.

Figure 15. Identification of HtsA mutations that impair SA-dependant growth of S.
aureus. S. aureus expressing HtsA R104A, R126A, or H209A are impaired for SAdependent growth. Inset, growth of all strains is restored with the addition of 50 pM
FeCfi, thus eliminating the requirement for Fe-SA iron for growth. Growth is in 80%
horse serum (Sigma) and 20% Chelex®-treated TMS. Error bars represent standard
deviation, n = 3.
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3.10. An alternate growth assay identifies that HtsA R86K, R104A, R126A, R126K,
K203A, H209A, H209Q, Y239A, and E110/250A mutants are impaired for Fe-SAdependent growth of S. aureus
Beasley et al. used disk diffusion assays, in addition to the liquid culture growth
curves, to further demonstrate the role of HtsABC in Fe-SA uptake (7). I used this assay
in an attempt to gain more insight into the role of HtsABC in SA-dependent growth.
Thus, disk-diffusion assays were completed for S. aureus Newman AhtsABC harboring
WT or mutant pEV55, using purified Fe-SA that was spotted onto the bacteriacontaining media. As illustrated in Figure 16, substitution of either HtsA R104A or
R126A completely abolished Fe-SA-dependant growth and substitution of HtsA H209A
significantly reduced Fe-SA-dependant growth. However, as opposed to the liquid
growth assay, this assay identified that substitution of HtsA R86K, R126K, K203A,
H209Q, Y239A, and El 10/250A also significantly reduced Fe-SA-dependent growth.
However, growth reductions associated with these additional residues were more
moderate. Importantly, this trend agrees with the binding affinity data. As a control, I
showed that no growth differences were observed when Fe-Desferal™ was used as the
iron source, demonstrating that the growth reductions observed were specific for Fe-SA.

Figure 16. Plate disk-diffusion growth assay confirms HtsA mutations that impair SAdependant growth of S. aureus. Growth promotion is measured as the diameter (mm) of
growth around each disk. The dashed line indicates the diameter of each disk and a
measurement of 6 mm indicates no growth. In panel A, Fe-SA is added as the sole iron
source, whereas in panel B, Fe-Desferal™ is added as the sole iron source. Error bars
represent standard deviation, n —3. Statistical significance is determined for each mutant
in comparison to WT. a P=<0.0001. b P=<0.001.c P=<0.05.
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Chapter 4 - Discussion

Bacterial pathogens must have the ability to scavenge host iron in order to
establish and maintain productive infections. S. aureus is one of the most successful
human pathogens, partly due to its enormous virulence factor repertoire and multiple
host iron-scavenging systems. Indeed, studies have demonstrated that disruption of
staphyloferrin B biosynthesis reduces S. aureus pathogenesis in a mouse model of
infection (32). Two staphylococcal siderophore systems have been genetically and
biologically characterized. The sfa and hts loci encode the SA biosynthesis machinery
(27) and ABC-transporter (7), respectively, and the sbn and sir operons encode the SB
biosynthesis machinery and ABC-transporter, respectively (32). Recently, our laboratory,
along with collaborators, published crystal structures of Fe-SA-rHtsA and Fe-SB-rSirA
(58, 57). HtsA was the first Gram-positive a-hydroxycarboxylate siderophore receptor
crystal structure. Although both SA and SB are anionic a-hydroxycarboxylate
siderophores, each receptor is specific for its cognate siderophore (58, 57). The hts
system is present ubiquitously among the chromosomes of sequenced Staphylococci
making it an ideal candidate for binding affinity and biological studies in order to
establish a model system of staphylococcal siderophore uptake.
The sfa locus was identified via bioinformatics searches and consists of genes
expressing two NIS synthetases, an exporter, and a PLP-dependant ornithine racemase
(27). The gene cluster is Fur regulated and is responsible for the synthesis and secretion
of SA (27). It is present in all sequenced Staphylococcal chromosomes, including
clinically relevant CoNS (7). SA has been isolated from culture supernatants of S. hyicus
and chemically characterized (80). More recently, the biosynthesis pathway of SA has
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been elucidated and it has been synthesized in vitro using rSfaB and rSfaD. One of the
first objectives of this study was to purify sufficient amounts of Fe-SA from in vitro
synthesis reactions.
Using the ion-pair HPLC strategy previously described, I separated Fe-SA from
reaction components and collected the fractions that corresponded to the Fe-SA peak
(27). This further purified the Fe-SA, a necessary step for its use in binding affinity
assays (58). Although CAS shuttle solution (133) has been used to normalize SA
siderophore units, it cannot be used to quantify the ion-pair HPLC fractions because they
were ferrated prior to injection onto the column (7). Therefore, I chose an indirect
approach to quantify the Fe-SA by using AAS to measure the amount of iron bound to
SA in the samples. With the known siderophore to iron binding ratio of 1:1,1 determined
the amount of Fe-SA present (58). This yielded sufficient amounts of Fe-SA for use in
experiments (~120 p,M).
The hts operon is located adjacent to the sfa locus and is also present in the
chromosomes of all sequenced staphylococci (7). It encodes a lipoprotein receptor and
two permeases that are necessary for Fe-SA transport (7). However, the hts operon was
first implicated in heme uptake following the observation that transposon disruption of
hts resulted in preferential uptake of transferrin Fe(III) over heme Fe(II) (137). This
phenomenon may be explained by a dual role of heme and Fe-SA uptake by the HtsBC
permeases (7). Indeed, Cuiv et al. demonstrated that a Sinorhizobium meliloti 2011
permease is involved in heme and hydroxamate siderophore uptake (31). However, it is
unlikely that HtsA functions as a heme binding protein, as the crystal structure of Fe-
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SA-rHtsA identifies Fe-SA in a highly positively charged binding pocket that is more
suitable for an anionic siderophore than a hydrophobic heme molecule (58).
One of the first major objectives of this study was to determine the binding
affinity of HtsA for Fe-SA. This information would allow better comparisons with
related proteins, provide insight on the mechanism of ligand binding, and further clarify
the role of HtsA in Fe-SA transport. Using the purified Fe-SA and rHtsA I determined
the Kd value of Fe-SA-rHtsA to be in the low nM range (58). This was the first
determination of the affinity between an a-hydroxycarboxylate siderophore and its
receptor (58). The strength of the affinity was not surprising considering that rHtsA
complexed and crystallized with Fe-SA when exposed to ferrated S. aureus culture
supernatant (58). The number of ionic contact points that rHtsA makes with Fe-SA in
combination with the envelopment of Fe-SA in the binding pocket likely explains the
high affinity. Furthermore, the affinity of rSirA for Fe-SB, another ahydroxycarboxylate siderophore-receptor complex, has recently been published and is
within the same range (57). Both affinities are within the range of several Gram-negative
bacteria outer membrane receptors for their respective ligands but they are significantly
greater than the affinity of E. coli FhuD (Table 1). The high affinities of HtsA and SirA
for Fe-SA and Fe-SB, respectively, are likely due to the number and type of ionic
interactions involved in siderophore co-ordination (58, 57). However, the significant
difference in their affinities compared to FhuD is likely accounted for by their ligand
repertoire. Indeed, whereas HtsA and SirA are specific for Fe-SA and Fe-SB,
respectively (58, 57), FhuD binds a broad range of Fe-hydroxamate siderophores (122),
and likely sacrifices affinity for broadened substrate specificity.
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Unique open and closed ligand-bound conformations allowed identification and
characterization of a novel form of ligand entrapment for a class III binding protein (58).
Many crystal structures of related proteins, such as BtuF (10, 78), TroA (86, 87), FhuD
(24, 82), and ShuT (67) have similar structural folds but little, if any, conformational
changes between apo and holo forms. Although FitE (136) and FeuA (112) both undergo
larger hinged movements more reminiscent of HtsA, their conformational changes are
characterized by rigid interdomain movement, whereas HtsA conformational changes
occur in isolated regions of the C-terminal domain (58). In addition, the unique HtsA
movements help occlude SA by shifting it deeper in the binding pocket, reducing solvent
exposure, and facilitating additional contact points (58). Only SirA has been
demonstrated to have similar C-terminal domain movements however, the
conformational changes, siderophore orientation, and receptor residues involved in
coordination are distinct and each receptor is specific for its cognate siderophore (58,
57).
One of the major objectives of this study was to identify and mutate what were
thought at the outset to be HtsA residues critical for Fe-SA interaction. Analysis of the
crystal structure identified many potential residues and I initially selected six amino
acids that form H-bonds with Fe-SA, R86, R104, R126, K203, H209, and Y239, and two
residues predicted to form salt-bridges that mediate docking with the permeases, HtsBC,
El 10 and E250 (58). In Grigg, Cooper, et al., we aligned 41 homologous sequences of
HtsA which showed that the residues selected were conserved to varying degrees, R86,
22/41; R104, 37/41; R126, 36/41; H209, 30/41; Y239, 9/41; El 10, 39/41; and E250,
38/41 (58). I created alanine amino acid substitutions of each residue as well as less
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drastic amino acid substitutions that aimed to conserve size, charge, or ring structure.
My studies focused on the contribution of each residue to productive SA binding or
transport. Before assessing their roles I confirmed that all mutant rHtsA could be
expressed, purified, and properly folded from E. coli. I also confirmed that they express
properly in S. aureus and localize to the cellular membrane.
To assess each residue’s importance for Fe-SA binding, I determined the effect
that each substitution had on the Fe-SA-rHtsA binding affinity. The four residue
substitutions that had the most drastic reductions of binding affinity were HtsA R104A,
R126A, R126K and H209A. Interestingly, R104, R126, and H209 are the only residues
investigated that form contacts with Fe-SA in both open and closed conformations of
HtsA. This highlights the importance of the initial contacts made in the open
conformation for Fe-SA binding. The R104 and R126 residues are also the most highly
conserved of the selected residues that form contacts with Fe-SA and their importance
for binding likely explains their degree of conservation. Furthermore, réintroduction of a
positive charge via R104K substitution rescued Fe-SA-rHtsA binding, whereas R126K
substitution did not. Therefore, the charge on residue R104 is likely the most important
factor for productive binding, but the charge and position of residue R126 are both
important. Substitution of H209A also eliminated measureable Fe-SA-rHtsA binding.
Interestingly, H209 is the third most conserved residue and substitution of H209Q re
established the low nM binding affinity of Fe-SA-rHtsA. This likely indicates an atom
capable of H-bonding (nitrogen in this case) is necessary and sufficient for binding at
residue H209. As expected, substitution of HtsA E250A, that is located outside of the
binding pocket and predicted to be involved in docking with HtsBC, did not change the
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Fe-SA-rHtsA binding affinity. More surprising however is that substitution of HtsA
K203A and Y239A, which are both involved in H-bonding with Fe-SA in the closed
conformation, did not affect the Fe-SA-rHtsA binding affinity. It was especially
interesting that the HtsA Y239A substitution did not elicit a pronounced effect because it
moved 12.1 A between the open and closed conformations before H-bonding and
enveloping Fe-SA in the binding pocket. Taken together, these results may indicate that
the contacts formed in the open conformation are the most important for binding,
whereas the contacts formed in the closed conformation may have more important roles
in the selectivity o f HtsA.
Another major focus of this research was to determine the significance that each
residue has on iron-restricted SA-dependant growth of S. aureus Newman. Interestingly,
the impact each HtsA residue substitution had on growth under these conditions
mirrored their effect observed on the Fe-SA-rHtsA binding affinity. Substitution of HtsA
R104A or R126A severely reduced S. aureus Newman growth. The binding affinity data
suggests that this was likely due to their inability to facilitate Fe-SA binding. However,
the ~700-fold reduction in binding affinity observed following substitution of HtsA
R126K did not confer a measureable growth defect. Two possible explanations may
account for this finding. First, pEV55 is a multi-copy vector and the subsequent increase
in HtsA expression may have compensated for the decreased binding affinity and
secondly, an ~700 nM Kd is still within the affinity range observed for FhuD and
therefore, may not sufficiently compromise Fe-SA-HtsA binding and transport.
Substitution of HtsA H209A severely delayed but did not eliminate growth. It is possible
that the reduction of growth was not as severe as seen for the substitutions of HtsA
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R104A or R126A because it was still able to bind Fe-SA sufficiently for transport.
Although the K^s of HtsA R104A, R126A, and H209A were not determined, the titration
of HtsA H209A with Fe-SA resulted and a greater reduction of the intrinsic fluorescence
which may indicate better binding (data not shown). Together with the lack of a growth
phenotype observed for the R126K substitution, substitution of HtsA H209A likely
permits sufficient Fe-SA binding to promote growth once enough HtsA is expressed,
explaining the delay. Unlike the Fe-SA-rHtsA binding affinity, substitution of HtsA
El 10/250A was expected to prevent docking of HtsA to HtsBC and therefore, prevent
transport of Fe-SA and growth under iron-restricted Fe-SA-dependant conditions.
However, no growth phenotype for HtsA El 10/250A was observed. This will be
examined in more detail below. Also, once again substitution of HtsA K203A or Y239A
did not affect the proper function of HtsA, as there was no observable growth phenotype
for either substitution. This further suggests that the additional Fe-SA-HtsA contacts
formed in the closed conformation of HtsA have a more significant role in ligand
specificity than for productive binding and transport. This will be addressed in more
detail in the future directions section of this thesis.
Finally, the last focus of my research was to use a disk diffusion assay as
previously described, to further examine the significance that each residue has on FeSA-dependent growth promotion of S. aureus Newman. Importantly, the HtsA residue
substitutions resulted in the same trend observed for growth promotion as seen in the
growth curves and Fe-SA-rHtsA binding affinities. However, the disk-diffusion growth
assay appeared to be more sensitive than the liquid growth assay. A possible explanation
for the assay’s increased sensitivity is the higher degree of iron restriction (7.5 pM
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EDDHA) used in the growth media. In addition to the HtsA substitutions identified in
the previous experiments, the substitution of HtsA R86K, R126K, K203A, H209Q,
Y239A, Y239F and El 10/250A, resulted in significantly reduced growth promotion,
albeit to a lesser degree than substitution of HtsA R104A, R126A, and H209A.
Interestingly, substitution of HtsA R104K did not result in a significant growth
phenotype and substitution of HtsA R126K only resulted in a modest growth reduction
that was comparable to the growth reductions observed following substitution of HtsA
R86K, K203A, H209Q, Y239F and El 10/250A. These proteins did not result in
decreased Fe-SA binding affinities however, this may be due to the reductions being too
subtle to detect with the concentration of HtsA used in the fluorescence titrations. Lower
protein concentrations may result in more accurate Kjs that reflect the same trend
observed for the growth reductions.
Although the results concerning the substitution of some of the HtsA residues
involved in Fe-SA binding were expected, two very surprising findings of this study was
the ability of the El 10/250A mutant derivative to facilitate productive transport of FeSA and the ability of the Y239A mutant derivative to facilitate productive binding and
transport of Fe-SA. This was surprising because HtsA El 10 and E250 are both highly
conserved (39/41 and 38/41, respectively) based on alignment of homologous HtsA
sequences, and modeling of HtsBC with the Fe-SA-rHtsA crystal structure predicted that
they are involved in Glu-Arg salt-bridge formation between the receptor and membrane
transporter (58). More importantly, similar salt-bridge formation and subsequent
docking with their cognate ABC-transporter is necessary for productive transport in
related proteins, including E. coli FecB (12) and S. aureus FhuD2 (134). However, my
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data suggest that the HtsBC permeases may be less reliant on those residues than FecB
or FhuD2 for docking of receptor and permease, or simply that the levels of SAdependent growth observed in my assays due to high levels of multicopy HtsABC
overshadowed any defects due to absence of the salt-bridge formation. As mentioned
earlier, the absence of an effect of substitution of HtsA Y239A on productive binding or
transport was also peculiar. Analysis of the open and closed forms of the Fe-SA-rHtsA
crystal structure revealed that Y239 traversed the binding pocket before H-bonding and
securing Fe-SA in the binding pocket. Furthermore, Y239 moves 12.1 A, the furthest of
any HtsA residue, and is part of an eight amino acid insertion that absent from all
homologous sequences (58). My data suggest that HtsA Y239 does not have a major role
in productive binding or transport of Fe-SA however, its role in the specificity of HtsA
for Fe-SA warrants further investigation.
In summary, I have determined the first Kd of an a-hydroxycarboxylate
siderophore and its receptor, developed a method of purifying and quantifying useful
quantities of Fe-SA from in vitro synthesis reactions, and analyzed and confirmed the
contribution of several amino acid residues identified from the Fe-SA-rHtsA crystal
structure. My methods will allow Fe-SA to be readily available for use in future
experiments and my results have clarified some of the conclusions drawn from analysis
of the crystal structure. For example, substitution of HtsA R104A, R126A, and H209A
confirmed the importance of the residues that bind Fe-SA in the open conformation but
substitution of HtsA Y239A and El 10/250A demonstrated the importance of verifying
conclusions drawn from analysis of a crystal structure or from comparison with
homologous proteins. Additionally, determination of the Fe-SA-rHtsA A^has facilitated
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comparison of HtsA with related class III binding proteins and Gram-negative outer
membrane receptor proteins.

Future Directions
My research has increased the understanding of S. aureus SA binding and
transport, the first such study involving a receptor protein for a polycarboxylate
siderophore. Moreover, through this work I have also provided tools (purified and
quantified Fe-SA) that can be used to facilitate greater knowledge of the staphylococcal
sfa-hts system, including the generation of additional sets of mutations in htsA and even
htsBC. One of the most interesting avenues of research that remains to be studied is
investigation of the importance of SA-mediated iron uptake in CoNS. There is no ironrestricted growth defect associated with the loss of sfa or hts in S. aureus, due to the
presence of the s,6«-s,/>-encoded SB iron uptake system. However, this latter system is
absent from all sequenced chromosomes of CoNS (7) and, therefore, in these organisms,
the sfa-hts system may take on a more prominent role in iron acquisition and potentially
virulence. Additionally, the contribution of HtsABC to heme uptake has yet to be
resolved. Thorough analysis of htsA and htsBC mutants or the identification of an
additional lipoprotein involved in heme uptake would clarify the role of the hts system
in staphylococci and significantly improve our understanding of S. aureus host ironuptake strategies. Also, because my results demonstrated the importance of verifying
conclusions drawn from a crystal structure, further investigations into the roles of the
residues that have been identified in the Fe-SB-rSirA crystal structure are warranted.
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